S&P 500
(0.27%) 5 475.09 points
Dow Jones
(0.13%) 39 170 points
Nasdaq
(0.83%) 17 879 points
Oil
(0.04%) $83.41
Gas
(-0.08%) $2.48
Gold
(0.12%) $2 341.70
Silver
(0.50%) $29.76
Platinum
(0.40%) $992.70
USD/EUR
(0.05%) $0.931
USD/NOK
(0.17%) $10.66
USD/GBP
(0.05%) $0.791
USD/RUB
(-0.01%) $86.75

Realtime updates for Axsome Therapeutics Inc [AXSM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
50.00%
return 1.49%
SELL
0.00%
return 2.13%
Last Updated1 Jul 2024 @ 16:00

0.66% $ 81.03

SELL 6335 min ago

@ $78.38

Issued: 27 Jun 2024 @ 10:32


Return: 3.38%


Previous signal: Jun 27 - 09:30


Previous signal: Buy


Return: 1.78 %

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.11% compare to its pairs and should correct upwards.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States...

Stats
Today's Volume 712 439
Average Volume 674 106
Market Cap 3.85B
EPS $-1.440 ( Q1 | 2024-05-06 )
Next earnings date ( $-1.320 ) 2024-08-05
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -12.56
(Sector) 42.63
(Industry) 24.32
ATR14 $1.740 (2.15%)
AADI -2.74%
ABCL -6.08%
ABCM 0.04%
ABEO -0.94%
ABIO -0.78%
ABOS -1.45%
ABSI -2.27%
ABUS 0.97%
ABVX 2.57%
ACAD -1.29%
ACER -17.95%
ACET -4.96%
ACGN 1.29%
ACHL -1.60%
ACHV 1.70%
ACIU -0.25%
ACLX -2.88%
ACRV 1.03%
ACST -2.34%
ACXP -4.89%
ADAG -0.33%
ADAP 7.70%
ADGI 0.87%
ADIL -5.22%
ADMA 3.31%
ADPT -0.55%
ADTX 14.49%
ADVM 1.60%
ADXN -12.26%
AEON -0.95%
AEZS 3.07%
AFMD -0.73%
AGEN -0.36%
AGIO 0.60%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -2.51%
AKRO -1.28%
AKTX 15.23%
AKUS 0.00%
ALBO 0.00%
ALDX -1.81%
ALEC -2.64%
ALGS 5.43%
ALKS 1.20%
ALLK -12.02%
ALLO 0.00%
ALLR 6.44%
ALNA 3.16%
ALNY 0.13%
ALPN 0.02%
ALPX 0.00%
ALRN 1.08%
ALT 8.27%
ALVR 0.93%
ALXN 0.00%
ALXO -0.66%
ALZN 0.91%
AMRN -0.29%
AMTI -3.13%
ANAB -1.80%
ANEB -1.83%
ANGN 0.00%
ANIX 0.45%
ANL -6.05%
ANNX 3.06%
ANPC -3.15%
APGE -1.96%
APGN 8.48%
APGNW 30.65%
APLM 0.96%
APLS -5.40%
APLT -1.28%
APM -7.51%
APOP 0.38%
APRE -0.98%
APTO -1.51%
APTX 3.17%
APVO 9.15%
ARAV -13.39%
ARCT -2.83%
ARDS 19.76%
ARDX 2.16%
ARGX 0.97%
ARNA 0.00%
ARPO -0.90%
ARQT 2.80%
ARTL -3.57%
ARTLW 0.00%
ARVN -2.40%
ARWR 0.23%
ASLN 0.00%
ASMB -3.50%
ASND -1.76%
ATAI 1.50%
ATHA -5.28%
ATHE 0.00%
ATHX -33.50%
ATNF -7.98%
ATOS 0.84%
ATRA -1.65%
ATXI -2.86%
ATXS 1.65%
AUPH -3.85%
AURA -2.51%
AUTL -0.29%
AVBP -2.16%
AVEO 0.00%
AVIR 1.81%
AVRO -1.41%
AVTE 2.41%
AVTX 1.12%
AVXL -2.61%
AXLA 0.00%
AXSM 0.66%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -0.51%
BCAB -1.46%
BCDA 0.67%
BCDAW 0.00%
BCEL 0.00%
BCLI 5.47%
BCRX 7.93%
BCTX -4.39%
BCTXW 17.17%
BCYC 0.25%
BDRX -0.23%
BDTX 0.86%
BEAM -1.62%
BFRA -2.91%
BGNE 1.56%
BIOR -4.56%
BIVI 4.00%
BLCM -6.68%
BLI -5.88%
BLPH -1.93%
BLRX -1.06%
BLTE 0.31%
BLU 0.03%
BLUE -0.90%
BMEA -1.78%
BMRN -0.24%
BNOX -10.04%
BNTC 3.92%
BNTX -1.90%
BOLD 8.27%
BOLT -2.41%
BPMC 1.30%
BPTH -3.00%
BPTS -13.47%
BRNS 2.14%
BRTX -2.46%
BTAI -8.59%
BTTX -15.97%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 2.92%
CABA 4.41%
CADL 1.61%
CALA 0.00%
CALC 7.32%
CALT -0.62%
CAPR 1.47%
CARA 1.94%
CARM 9.87%
CASI -1.82%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.89%
CCCC 4.98%
CCXI 0.00%
CDAK 0.00%
CDIO -1.82%
CDIOW 6.00%
CDMO -0.28%
CDMOP 0.04%
CDT -6.12%
CDTTW 72.08%
CDTX 0.84%
CDXC -1.47%
CDXS -3.55%
CELC 1.59%
CELU 1.92%
CELUW 1.32%
CERC -1.68%
CERE 1.13%
CERO -8.16%
CEROW 43.57%
CFRX -27.95%
CGEM -4.07%
CGEN 4.17%
CGON 0.48%
CGTX 0.60%
CHMA -6.00%
CHRS -6.94%
CINC 0.00%
CING 7.50%
CINGW 4.85%
CKPT -4.65%
CLBS -16.75%
CLDX 5.35%
CLGN 1.00%
CLLS 3.48%
CLNN 0.22%
CLNNW 44.05%
CLRB 2.00%
CLSD -4.62%
CLSN -0.68%
CLVS 0.00%
CMMB 5.00%
CMND -1.19%
CMPI 0.00%
CMPX -5.45%
CMRA 0.00%
CMRAW 33.33%
CMRX -0.80%
CNCE 0.00%
CNSP -10.13%
CNST 0.00%
CNTA -2.55%
CNTB -5.26%
CNTX -9.73%
COCP 3.00%
COEPW 0.00%
COGT 6.05%
CORT 0.55%
COYA 0.66%
CPRX 1.81%
CRBP 9.17%
CRBU -3.05%
CRDF -7.66%
CRGX -2.56%
CRIS -7.54%
CRNX 2.86%
CRSP -0.11%
CRTX 2.63%
CRVO -5.84%
CRVS 1.65%
CSBR -4.26%
CTCX 23.31%
CTIC 0.06%
CTMX 9.02%
CTNM 19.25%
CTXR -6.92%
CUE -17.74%
CVAC -2.06%
CVKD -1.15%
CWBR 0.00%
CYAD -12.96%
CYCC 0.00%
CYCCP -11.68%
CYCN 0.88%
CYT -2.27%
CYTK 0.96%
CYTO 9.91%
DARE -6.03%
DAWN -1.45%
DBTX -0.81%
DBVT 2.20%
DFFN 10.28%
DICE 0.06%
DMAC 0.00%
DNLI -5.21%
DNTH 11.55%
DOMH 4.81%
DRMA -5.37%
DRMAW 7.69%
DRNA 0.00%
DRTS 0.79%
DRTSW 19.05%
DRUG -2.77%
DSGN -2.99%
DTIL 1.64%
DYAI 3.38%
EARS -1.77%
EDIT -1.28%
EDSA 2.09%
EFTR -8.00%
EFTRW -41.67%
EIGR -9.21%
ELAB 0.07%
ELDN -4.92%
ELEV 5.93%
ELOX 1.45%
ELTX -8.03%
ELVN -2.87%
ELYM -0.84%
ENGN -4.03%
ENGNW -2.88%
ENLV -2.82%
ENOB 1.79%
ENSC -1.23%
ENTA 0.77%
ENTO -11.11%
ENTX -4.35%
ENVB -5.90%
EPIX -2.66%
EPRX 2.38%
EPZM 0.00%
EQ -2.21%
EQRX -2.09%
EQRXW 0.00%
ERAS 3.39%
ERNA 4.14%
ERYP 1.30%
ESLA 4.76%
ESLAW 0.00%
ETNB -3.12%
ETON 3.34%
ETTX 0.00%
EVAX 0.70%
EVGN -0.91%
EVLO 39 899.32%
EWTX 7.61%
EXAI 0.98%
EXEL -0.98%
EYEG -0.51%
EYEN 14.27%
EYPT -4.48%
FATE -0.61%
FBIO -1.17%
FBIOP 0.70%
FBLG -19.84%
FBRX 1.68%
FDMT 1.67%
FENC 2.62%
FGEN -13.69%
FHTX 1.57%
FIXX 0.77%
FMTX 0.00%
FNCH -10.95%
FOLD -1.21%
FREQ 4.76%
FRLN 0.15%
FRTX -4.21%
FSTX 0.00%
FTRE 2.23%
FULC 1.77%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.98%
GANX -12.50%
GBIO -8.87%
GBT 0.01%
GDTC -0.99%
GERN 2.36%
GHRS 0.77%
GLMD -1.01%
GLPG 0.93%
GLSI -2.84%
GLTO -1.73%
GLUE 5.35%
GLYC 5.15%
GMAB -1.11%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 10.80%
GNLX -5.64%
GNPX 2.39%
GNTA -0.87%
GOSS 5.18%
GOVX 2.98%
GOVXW -10.37%
GPCR 1.86%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -6.13%
GRTX -8.63%
GTHX 8.33%
GUTS 4.45%
GXGXW 41.67%
GYRE 0.92%
HALO -0.65%
HARP 0.09%
HCWB 0.46%
HEPA -0.93%
HGEN -84.62%
HILS 5.66%
HLVX -0.28%
HOOK 6.17%
HOTH -1.12%
HOWL -3.69%
HRMY 0.83%
HRTX -0.86%
HSTO 0.00%
HUMA 11.88%
HUMAW 22.30%
IBRX -0.79%
ICCC -8.04%
ICPT 0.21%
ICU 23.06%
ICUCW 13.26%
ICVX -0.91%
IDRA -23.04%
IDYA 2.31%
IFRX -1.72%
IGMS -1.16%
IKNA 0.00%
IKT -5.34%
IMAB -2.99%
IMCR 7.49%
IMGN 0.02%
IMGO 0.00%
IMMP 0.00%
IMMX 7.07%
IMNM 0.83%
IMNN 8.62%
IMPL -27.27%
IMRA 15.96%
IMRN -9.26%
IMRX -8.59%
IMTX 3.27%
IMTXW 27.41%
IMUX 0.90%
IMV 0.00%
IMVT 4.20%
INAB -3.95%
INBX -3.03%
INCY 0.41%
INDP 4.25%
INFI -52.38%
INKT -3.51%
INM -5.24%
INMB -4.54%
INO 6.56%
INSM -0.99%
INTS 0.41%
INVA 0.61%
INZY -1.12%
IOBT -4.27%
IONS -1.15%
IOVA 0.50%
IPA -3.71%
IPHA 7.22%
IPSC -5.49%
IRON 3.11%
ISEE 0.38%
ITOS 1.15%
ITRM -5.60%
IVA -1.19%
IVVD 9.09%
JAGX -2.79%
JANX -0.41%
JAZZ -0.24%
JNCE 0.00%
JSPR 1.94%
JSPRW 5.15%
JUNS 0.00%
JUNSW 0.00%
KA 4.20%
KALV 0.93%
KDNY 0.22%
KMPH -0.34%
KNSA -3.59%
KNTE -0.38%
KOD 0.85%
KPRX 3.57%
KPTI -6.01%
KRBP -1.83%
KRON -9.68%
KROS -4.22%
KRRO -0.06%
KRTX 0.03%
KRYS -0.75%
KTRA 10.14%
KTTA 0.38%
KTTAW 1.83%
KURA 2.96%
KYMR 3.69%
KYTX 4.13%
KZIA -4.91%
KZR -2.73%
LABP 0.57%
LBPH 14.39%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.91%
LENZ 2.31%
LEXX -0.72%
LEXXW 23.90%
LGND 0.70%
LGNDV 0.00%
LGVN -2.48%
LIAN -8.28%
LIFE 2.70%
LIPO -3.41%
LIXT -0.38%
LIXTW -3.71%
LJPC -0.32%
LMNL 0.12%
LOGC -3.15%
LPCN -6.31%
LPTX -4.59%
LQDA 0.33%
LRMR 13.66%
LSTA 2.31%
LTRN -3.21%
LUMO -2.46%
LVTX 3.89%
LXEO -2.68%
LXRX -0.30%
LYEL 8.97%
LYRA 7.30%
MACK 0.10%
MBIO 2.41%
MBRX -1.15%
MCRB -0.25%
MDGL -0.30%
MDNA -13.16%
MDWD -0.84%
MDXG -3.32%
MEIP -2.06%
MESO -0.44%
MGNX 1.18%
MGTA -7.74%
MGTX -2.61%
MGX 8.33%
MIRM -0.09%
MIRO 0.59%
MIST 0.75%
MITO 0.00%
MLEC -0.88%
MLECW -31.50%
MLND -5.36%
MLTX -4.94%
MLYS 4.02%
MNKD -2.49%
MNMD -1.94%
MNOV 0.00%
MNPR -0.88%
MOLN 2.80%
MOR -0.22%
MORF -4.46%
MREO 0.83%
MRKR -0.74%
MRNA -2.36%
MRNS 9.40%
MRSN -1.99%
MRTX -0.17%
MRUS -7.98%
MRVI -3.07%
MTCR -1.29%
MTEM 2.61%
MTP -18.50%
MURA -0.96%
MYMD 0.00%
NAMS 7.13%
NAMSW -4.76%
NAUT -2.99%
NBRV 0.71%
NBSE -1.56%
NBTX 7.00%
NCNA 7.36%
NERV -0.86%
NEXI -6.90%
NGM -1.28%
NGNE 11.62%
NKGN 0.00%
NKGNW -12.00%
NKTR -1.61%
NKTX -1.02%
NLSP -9.50%
NLSPW 26.58%
NMRA 1.12%
NMTR -42.97%
NOVN -24.84%
NRBO -6.20%
NRIX 0.19%
NRSN -3.57%
NRSNW -2.91%
NRXP 5.74%
NRXPW 41.43%
NRXS 1.44%
NTBL -6.12%
NTEC -12.45%
NTHI 0.00%
NTLA 0.40%
NTRBW 74.65%
NUVL -0.46%
NVAX 0.55%
NVCT -2.37%
NVIV -34.28%
NXTC -5.66%
NYMX -0.05%
OABI -0.27%
OABIW -9.28%
OBIO -12.64%
OBSV 0.00%
OCEA -3.28%
OCGN 4.84%
OCS -0.50%
OCUL -2.63%
OCUP 3.92%
ODT -4.27%
OKYO 1.64%
OLMA 2.96%
OMER -2.71%
OMGA 8.70%
ONCO -6.10%
ONCR -3.08%
ONCS 31.87%
ONCT -7.70%
ONCY 0.53%
ONTX -0.47%
ONVO -0.34%
OPNT 0.00%
OPT -0.99%
ORGS 8.13%
ORIC 8.06%
ORMP -0.39%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.41%
OVID 12.09%
OYST 0.00%
PALI -5.29%
PASG 11.43%
PBLA -10.00%
PBM 6.33%
PBYI 0.61%
PCSA -7.11%
PCVX 1.89%
PDSB 3.41%
PEPG 12.22%
PGEN -1.90%
PHAR -4.62%
PHAS 0.00%
PHAT 4.95%
PHIO -3.88%
PHIOW 36.47%
PHVS -0.59%
PHXM -5.20%
PIRS -1.82%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 1.02%
PLUR -0.43%
PMN 6.67%
PMVP -2.47%
PNT 0.16%
PPBT -13.47%
PRAX -0.41%
PRDS 0.93%
PRLD -1.05%
PROG -3.47%
PROK 1.63%
PRQR -0.60%
PRTA -0.78%
PRTC 3.68%
PRTG -7.63%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 2.04%
PSTX 3.08%
PTCT 1.93%
PTE -0.82%
PTGX 1.59%
PTIXW -48.41%
PULM 1.55%
PXMD -1.27%
PYPD -0.24%
PYXS -3.32%
QLGN -3.77%
QNCX -3.33%
QNRX 1.75%
QSI -11.01%
QSIAW 4.08%
QTTB 5.74%
QURE -0.78%
RAIN -1.63%
RANI 0.53%
RAPT -5.57%
RARE 0.05%
RCKT -4.04%
REGN 0.57%
RENB -10.86%
REPL 4.00%
RETA 0.02%
REUN -0.89%
REVB -1.58%
REVBU 3.46%
REVBW 0.00%
RGLS 6.44%
RGNX -5.38%
RIGL 2.31%
RLAY -1.84%
RLMD 2.33%
RLYB 1.49%
RNA 1.05%
RNAC -10.14%
RNAZ -4.54%
RNXT 1.77%
ROIV 2.46%
ROIVW 4.56%
RPHM 2.65%
RPRX -0.68%
RPTX 0.91%
RUBY 2.70%
RVLP -32.05%
RVMD 0.00%
RVMDW -1.40%
RVNC 0.00%
RVPH -7.03%
RVPHW 4.88%
RXDX 0.09%
RXRX -0.53%
RYTM 3.92%
RYZB 0.02%
RZLT 0.23%
SABS -1.94%
SABSW 54.57%
SAGE 1.57%
SANA 0.18%
SAVA -1.70%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 3.16%
SCPH -0.69%
SCPS 0.00%
SEEL 3.69%
SEER 0.60%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -7.90%
SGMT -7.60%
SGTX -2.56%
SIOX 22.63%
SLDB 10.58%
SLGL -4.21%
SLN -1.37%
SLNO 3.65%
SLRX -7.92%
SLS -0.84%
SMMT 4.36%
SNDX 4.87%
SNGX -4.26%
SNPX 1.97%
SONN -0.80%
SPPI -0.49%
SPRB 2.55%
SPRC -5.98%
SPRO -1.54%
SRNE -20.00%
SRPT -0.79%
SRRA 0.00%
SRRK -2.40%
SRZN -2.28%
STAB 0.00%
STOK 2.66%
STRO 4.10%
STSA 0.00%
STTK 3.37%
SURF -0.93%
SVRA 15.14%
SWTX 2.28%
SYBX -0.67%
SYRS -4.46%
TALS -0.73%
TARA 0.48%
TARS 3.90%
TBPH 0.47%
TCBP 1.76%
TCDA 0.00%
TCON -30.63%
TCRR 0.00%
TCRT -6.87%
TCRX 1.37%
TECH -0.06%
TENX -1.32%
TERN 0.59%
TFFP 7.23%
TGTX 2.02%
THRX 0.12%
TIL 0.10%
TLC 0.00%
TLSA -3.63%
TNGX 4.90%
TNXP 4.96%
TNYA 8.71%
TPST -2.28%
TRDA 0.49%
TRVI -3.02%
TRVN -3.81%
TSHA 0.89%
TSVT 5.19%
TTNP -0.18%
TVTX 0.73%
TYRA 8.07%
UBX -1.48%
UNCY 7.76%
URGN -1.79%
UTHR 0.14%
VACC 11.36%
VALN -3.27%
VAXX 20.24%
VBIV 4.85%
VBLT -8.77%
VCEL -1.85%
VCNX -0.15%
VCYT -1.57%
VERA 0.30%
VERU 4.45%
VERV 2.05%
VIGL 9.25%
VINC -6.26%
VIR 2.25%
VIRI 3.26%
VIRX -6.20%
VKTX 4.36%
VLON -13.04%
VNDA -1.24%
VOR -1.07%
VRCA 9.05%
VRDN 1.54%
VRNA 7.26%
VRPX -1.59%
VRTX 0.54%
VSTM 9.06%
VTGN 2.59%
VTVT -0.42%
VTYX -2.16%
VXRT 3.19%
VYGR -0.63%
VYNE -2.54%
VYNT 7.78%
WINT 0.00%
WVE 4.91%
XBIO -0.48%
XBIT 7.98%
XCUR -3.93%
XENE -3.33%
XERS -3.56%
XFOR 1.62%
XLO -2.49%
XLRN 0.00%
XNCR 0.48%
XOMA 5.11%
XOMAO 0.20%
XOMAP 1.98%
XRTX -1.06%
YMAB -2.07%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -0.23%
ZNTL 2.45%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-07 Mahony Susan Buy 5 799 Stock Option (Right to Buy)
2024-06-07 Coleman Mark Buy 5 799 Stock Option (Right to Buy)
2024-06-07 Jeffs Roger Buy 5 799 Stock Option (Right to Buy)
2024-06-07 Saad Mark E Buy 5 799 Stock Option (Right to Buy)
2024-05-29 Jacobson Mark L. Buy 13 693 Common Stock
INSIDER POWER
51.04
Last 99 transactions
Buy: 1 985 054 | Sell: 314 752
Correlation (AI algo v.1.1b): Undervalued: 0.11% $81.20 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.29 (neutral)
Short: 0.59 (weak)
Signal:(54) Neutral

Axsome Therapeutics Inc Correlation

10 Most Positive Correlations
OZEM1
BDSX0.866
AAPD0.863
LTRX0.863
CBFV0.861
DBX0.86
SMSI0.859
GASS0.856
SSP0.849
LDWY0.848
10 Most Negative Correlations
SEMPX-0.912
FDCF-0.904
PRCNX-0.892
MPIEX-0.888
NRIX-0.884
HOOD-0.88
ALTEX-0.88
AKLI-0.879
MACSX-0.878
VNOM-0.877

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Axsome Therapeutics Inc Correlation - Currency/Commodity

The country flag 0.14
( neutral )
The country flag 0.35
( neutral )
The country flag 0.00
( neutral )
The country flag 0.32
( neutral )
The country flag 0.56
( weak )
The country flag 0.39
( neutral )

Axsome Therapeutics Inc Financials

Annual 2023
Revenue: $270.60M
Gross Profit: $237.70M (87.84 %)
EPS: $-5.27
FY 2023
Revenue: $270.60M
Gross Profit: $237.70M (87.84 %)
EPS: $-5.27
FY 2022
Revenue: $50.04M
Gross Profit: $44.84M (89.61 %)
EPS: $-4.86
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-3.47

Financial Reports:

No articles found.

Axsome Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Axsome Therapeutics Inc

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.5919709205627 seconds
Number of API calls: 3
Number of DB calls: 9